Covaxin receives GMP certificate from Hungary: Bharat Biotech
The Hindu
This is the 1st EUDRAGDMP compliance certificate received by Bharat Biotech from European regulatories, says the tweet.
Bharat Biotech's COVID-19 vaccine Covaxin has received Good Manufacturing Practices (GMP) compliance certificate from Hungary, the vaccine maker said on Thursday in a tweet. "Another milestone in our account as COVAXIN receives GMP certificate from Hungary. This marks the 1st EUDRAGDMP compliance certificate received by Bharat Biotech from European regulatories," the tweet said. The approval received is from the National Institute of Pharmacy and Nutrition, Hungary certifying the GMP for the manufacture of Covaxin, a note posted on Twitter said.More Related News